Penumbra
PEN
#1772
Rank
โ‚น793.13 B
Marketcap
โ‚น20,666
Share price
1.81%
Change (1 day)
6.46%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Revenue for Penumbra (PEN)

Revenue in 2024 (TTM): โ‚น97.09 Billion

According to Penumbra's latest financial reports the company's current revenue (TTM ) is โ‚น98.22 Billion. In 2023 the company made a revenue of โ‚น88.12 Billion an increase over the revenue in the year 2022 that were of โ‚น70.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Penumbra from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น97.09 B10.18%
2023 โ‚น88.12 B25.71%
2022 โ‚น70.10 B25.98%
2021 โ‚น55.64 B35.77%
2020 โ‚น40.98 B4.99%
2019 โ‚น39.03 B25.47%
2018 โ‚น31.11 B45.99%
2017 โ‚น21.31 B19.1%
2016 โ‚น17.89 B44.69%
2015 โ‚น12.36 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น48.49 B-50.64%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น111.91 B 13.93%๐Ÿ‡บ๐Ÿ‡ธ USA